India, May 1 -- Biotechnology company Biogen, Inc. (BIIB) reported Thursday that net income attributable to the company for the first quarter grew to $240.5 million or $1.64 per share from $393.4 million or $2.70 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter were $3.02 per share, compared to $3.67 per share in the year-ago quarter.
On average, 24 analysts polled expected the company to report earnings of $2.96 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenue for the quarter grew 6 percent to $2.43 billion from $2.29 billion in the same quarter last year. Revenues were up 8 percent in constant currency. Analysts expected revenues of $2.23 billion for th...